中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
25期
31-32
,共2页
美沙拉嗪%双歧三联活菌%溃疡性结肠炎
美沙拉嗪%雙歧三聯活菌%潰瘍性結腸炎
미사랍진%쌍기삼련활균%궤양성결장염
Mesalazine%Bifid tiple viable%Ulcerative colitis
目的:探讨美沙拉嗪联合双歧三联活菌治疗溃疡性结肠炎的临床疗效.方法:收治溃疡性结肠炎患者 76例,随机分为观察组和对照组,每组38例.对照组予以美沙拉嗪缓释颗粒剂,观察组给予美沙拉嗪颗粒联合双歧三联活菌胶囊.观察两组疗效.结果:观察组总有效率92.11%显著高于对照组的73.68%(P<0.05);两组治疗后DAI评分及内镜评分均显著低于治疗前(P<0.05),且治疗后观察组DAI评分及内镜评分均显著低于对照组(P<0.05);观察组治疗前后MDA水平差值和SOD活力差值明显高于对照组(P<0.05).结论:美沙拉嗪联合双歧三联活菌治疗溃疡性结肠炎临床疗效显著.
目的:探討美沙拉嗪聯閤雙歧三聯活菌治療潰瘍性結腸炎的臨床療效.方法:收治潰瘍性結腸炎患者 76例,隨機分為觀察組和對照組,每組38例.對照組予以美沙拉嗪緩釋顆粒劑,觀察組給予美沙拉嗪顆粒聯閤雙歧三聯活菌膠囊.觀察兩組療效.結果:觀察組總有效率92.11%顯著高于對照組的73.68%(P<0.05);兩組治療後DAI評分及內鏡評分均顯著低于治療前(P<0.05),且治療後觀察組DAI評分及內鏡評分均顯著低于對照組(P<0.05);觀察組治療前後MDA水平差值和SOD活力差值明顯高于對照組(P<0.05).結論:美沙拉嗪聯閤雙歧三聯活菌治療潰瘍性結腸炎臨床療效顯著.
목적:탐토미사랍진연합쌍기삼련활균치료궤양성결장염적림상료효.방법:수치궤양성결장염환자 76례,수궤분위관찰조화대조조,매조38례.대조조여이미사랍진완석과립제,관찰조급여미사랍진과립연합쌍기삼련활균효낭.관찰량조료효.결과:관찰조총유효솔92.11%현저고우대조조적73.68%(P<0.05);량조치료후DAI평분급내경평분균현저저우치료전(P<0.05),차치료후관찰조DAI평분급내경평분균현저저우대조조(P<0.05);관찰조치료전후MDA수평차치화SOD활력차치명현고우대조조(P<0.05).결론:미사랍진연합쌍기삼련활균치료궤양성결장염림상료효현저.
Objective:To explore the clinical curative effect of mesalazine combined with bifid tiple viable in the treatment of ulcerative colitis.Methods:76 patients with ulcerative colitis were selected.They were randomly divided into the observation group and the control group with 38 cases in each.The control group were given mesalazine,and the observation group were given mesalazine combined with bifid tiple viable,then we compared the effect of two groups.Results:The total effective rate(92.11%) of the observation group was significantly higher than 73.68% of the control group(P<0.05).The DAI scores and endoscopic scores after treatment in two groups were significantly lower than those before treatment(P<0.05).The DAI scores and endoscopic scores after treatment in the observation group were significantly lower than those of the control group(P<0.05).The MDA level difference value and SOD vitality difference value before and after treatment in the observation group were significantly higher than those of the control group(P<0.05).Conclusion:Mesalazine combined with bifid tiple viable in the treatment of ulcerative colitis has a significant clinical curative effect.